Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

National Health Investors Inc gives FY 2014 FFO guidance above analysts' estimates


Monday, 5 May 2014 01:00am EDT 

National Health Investors Inc:Sees FY 2014 FFO from $4.14 to $4.20 per diluted common share.Sees FY 2014 Normalized AFFO from $3.69 to $3.75 per diluted common share.FY 2014 FFO estimates of $4.08 - Thomson Reuters I/B/E/S. 

Company Quote

66.28
-0.27 -0.41%
28 Nov 2014